4//SEC Filing
HAEMONETICS CORP 4
Accession 0001127602-15-029500
$HAECIK 0000313143operating
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 5:18 PM ET
Size
9.6 KB
Accession
0001127602-15-029500
Insider Transaction Report
Form 4
Jesse Sandra
VP & CLO
Transactions
- Award
Performance Shares
2015-10-20+6,646→ 6,646 totalExercise: $0.00From: 2018-09-30Exp: 2018-12-31→ Common Stock (6,646 underlying) - Award
Common Stock
2015-10-20$0.01/sh+3,323$33→ 17,971 total - Award
Non-qualified Stock Option (Right to Buy)
2015-10-20$31.97/sh+14,608$467,018→ 14,608 totalExercise: $31.97From: 2016-10-20Exp: 2022-10-20→ Common Stock (14,608 underlying)
Footnotes (3)
- [F1]Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F2]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
- [F3]Performance Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Performance Share Unit based on the performance of Haemonetics stock price relative to the Standard & Poors Health Care Equipment Index. The number of Performance Share Units (and therefore the number of shares payable) will depend on the Company's stock price performance between October 1, 2015 and September 30, 2018. The Performance Share Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to twice the target amount in column 5. The Performance Share Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000313143
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 5:18 PM ET
- Size
- 9.6 KB